1. Home
  2. BDSX vs ECF Comparison

BDSX vs ECF Comparison

Compare BDSX & ECF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$22.15

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Logo Ellsworth Growth and Income Fund Ltd.

ECF

Ellsworth Growth and Income Fund Ltd.

HOLD

Current Price

$12.81

Market Cap

176.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
ECF
Founded
2005
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
153.3M
176.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
ECF
Price
$22.15
$12.81
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
89.7K
24.8K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
N/A
6.42%
EPS Growth
N/A
N/A
EPS
N/A
0.46
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
N/A
P/E Ratio
N/A
$27.57
Revenue Growth
24.08
N/A
52 Week Low
$0.29
$10.33
52 Week High
$24.92
$13.85

Technical Indicators

Market Signals
Indicator
BDSX
ECF
Relative Strength Index (RSI) 61.82 47.41
Support Level $6.63 $12.70
Resistance Level $24.92 $13.17
Average True Range (ATR) 2.39 0.24
MACD 0.01 -0.06
Stochastic Oscillator 71.93 41.68

Price Performance

Historical Comparison
BDSX
ECF

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

Share on Social Networks: